Skip to content
Open access

Contributions of smoking behaviour to lung cancer subtypes

Oct 2026 · Medicine · Vol 105 · 0 citations · 20 references
Medicine

TL;DR

The results indicate that reducing consumption among established smokers warrants emphasis alongside preventing uptake, and smoking intensity shows robust causal effects on all smoking-related LC subtypes, whereas the evidence for smoking status is directionally consistent but considerably weaker.

Abstract

Smoking is an established cause of lung cancer (LC), but the relative causal contributions of whether a person ever smokes and how heavily they smoke across histological subtypes remain uncertain. This study investigated the causal effects of smoking status and smoking intensity on major LC subtypes. Two-sample Mendelian randomization (MR) was performed. Genetic instruments were drawn from the GWAS and Sequencing Consortium of Alcohol and Nicotine Use: 85 variants for smoking status, a binary trait contrasting ever with never smokers, and 23 variants for smoking intensity, a continuous trait measuring cigarettes smoked per day. Outcomes were 5 LC phenotypes from FinnGen: non-small cell LC (1627 cases), adenocarcinoma (571), squamous cell carcinoma (365), small cell LC (179), and mesothelioma (133). Inverse-variance weighted regression with multiplicative random effects was the primary estimator, with weighted median, weighted mode, and MR-Egger as sensitivity analyses. Benjamini–Hochberg correction was applied across all ten tests. Analyses used R 4.2.3 with TwoSampleMR 0.7.9. Smoking intensity was causally associated with all 4 smoking-related subtypes: squamous cell carcinoma (odds ratio [OR]: 5.95 per standard deviation increase, 95% confidence interval [CI]: 3.12–11.37), small cell LC (OR: 4.43, 95% CI: 1.60–12.32), non-small cell LC (OR: 3.45, 95% CI: 2.30–5.18), and adenocarcinoma (OR: 2.66, 95% CI: 1.40–5.06). All 4 survived correction for multiple testing and were reproduced by the weighted median and weighted mode estimators. Smoking status showed positive point estimates for all 4 subtypes (OR: 1.40–1.61) but reached only nominal significance for non-small cell LC (OR: 1.51, 95% CI: 1.04–2.19, P = .030), which did not survive correction and was not reproduced by other estimators. Neither exposure was associated with mesothelioma. Smoking intensity shows robust causal effects on all smoking-related LC subtypes, whereas the evidence for smoking status is directionally consistent but considerably weaker. The null finding for mesothelioma, a cancer principally caused by asbestos, supports the specificity of the instruments. These results indicate that reducing consumption among established smokers warrants emphasis alongside preventing uptake.

Read PDF

Similar papers

Open access Sep 2026

Epigenetic Predictors of Smoking: External Validation and Association With Smoking-Related Cancer Risk.

In middle-aged and older Australians, DNAm-based smoking predictors showed very good reliability and accuracy in predicting smoking exposure, and strong positive associations with smoking-related cancer risk beyond self-reported smoking information.

Xiao-Yu Fan, D. L. Li, Allison M. Hodge et al. · 0 citations
Open access Oct 2026

Global cancer burden attributable to tobacco smoking in 2022: a differential analysis by smoking status, sex, and development level

Abstract Background Tobacco smoking is a leading preventable cause of cancer. We estimated its attributable cancer burden by smoking status (current vs. former), further stratified by cancer type, sex, country, and Human Development Index (HDI). Methods The Population Attributable Fraction (PAF) for cancer incidence an...

Veer Shah, Darshi Shah, Karan Shah et al. · 0 citations
Nov 2026

Abstract 17059: Smoking and Cessation, DNA Methylation, and Mortality

Background: Self-reported smoking history is susceptible to measurement errors. Although DNA methylation (DNAm) may serve as a biologically relevant long-term biomarker of smoking exposure, there remains a lack of a signature that accurately quantifies DNAm profiles after cessation. Moreover, it remains unclear whet...

Si-Dong Li, Brian H. Chen, Jun Li et al. · 0 citations
Open access Oct 2026

Causal association between tobacco use, fibroblast growth factors, and pulmonary fibrosis: A two-sample Mendelian randomization study

Introduction Cigarette smoking is a risk factor for pulmonary fibrosis, but its underlying mechanisms remain unclear. Fibroblast growth factors (FGFs) have been implicated in pulmonary fibrosis, yet their role in smoking-induced pulmonary fibrosis remains unclear. This study employed Mendelian randomization (MR) analys...

Ren-Zhi Yu, Xiao Han, Ming-Huan Wang et al. · 0 citations
Open access Oct 2026

Lung Function–Associated Genetic Variants and Overall Survival in Non–Small Cell Lung Cancer: A Multi-Platform Analysis

Background: Genome-wide association studies (GWAS) have identified numerous variants associated with spirometric lung function, and Mendelian randomization studies suggest that impaired pulmonary function contributes to lung cancer susceptibility. Whether these variants influence survival after non–small cell lung canc...

Zhan-Xia Li, Zhi-Lin Zhang, Yu-Chen Zhao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.